BMS-986470

N/A

Report date: 2025/12/10 17:21:58
NME

Base Information

Drug NameBMS-986470
Drug Alias NameBMS-986470
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCereblon modulatorsUbiquitin-protein ligases modulators
TargetsCereblonUbiquitin-protein ligases
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A